Gary Palmer's Biography

Gary Palmer, Senior Vice President, Foundation Medicine Inc

Dr. Palmer is a medical oncologist with a career spanning three decades in oncology, initially as a clinician in both the academic and community settings and then as a biotech industry executive with diagnostic and therapeutic experience.

Dr. Palmer joins Foundation Medicine from On-Q-ity, where he was chief medical officer and head of development for DNA repair marker development and circulating tumor cell technology. He also served as vice president of medical affairs at Genomic Health, Inc., where he was instrumental in the commercialization of the Oncotype DX Breast Cancer Assay. Prior to Dr. Palmer’s tenure with Genomic Health, he held leadership positions at Kosan Biosciences and Salmedix, Inc. He also spent five years at Amgen, Inc. where he was involved in the clinical development and commercialization of Neupogen, Neulasla and Aranesp.

Prior to joining industry, he served as director of the Medical Breast Service at the University of California Davis Cancer Center and chief of medical oncology at Mercy Health System, Sacramento.

Dr. Palmer received a BA from Yale University and an MD from the Stanford University School of Medicine. He completed his internal medicine training at the Boston City Hospital and his oncology fellowship at the Massachusetts General Hospital. He also holds an MBA from the University of California, an MPH from the University of California, Los Angeles and a JD from Concord University. He is a licensed physician and a member of the State Bar of California.